跳至主要内容
临床试验/NCT01410903
NCT01410903终止不适用

Immunoadsorption in Addition to the Established Therapy in Patients With Systemic Sclerosis

GWT-TUD GmbH2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
GWT-TUD GmbH
入组人数
1
试验地点
2
主要终点
survival under immunoadsorption

研究概览

简要总结

The purpose of this study is to evaluate source data for the survival and the investigation of the preliminary efficacy of immunoadsorption in patients with severe systemic sclerosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • systemic sclerosis according to the ACE-criteria
  • severe pulmonary manifestation with reduced DLCO
  • signed informed consent

排除标准

  • inadequate peripheral venous access
  • participation in another clinical trial
  • heart failure
  • pronounced allergic diathesis, particularly in case of known hypersensitivity to drugs and/or materials used in the extracorporeal circuit

结局指标

主要结局

survival under immunoadsorption

时间窗: 6 months

次要结局

  • survival under immunoadsorption(12 months)
  • Number of Serious Adverse Events(12 months)
  • change in "modified Rodnan Skin Score"(12 months)
  • change in Diffusing Capacity of the Lung for Carbon Monoxide(12 months)
  • change in Scleroderma Health Assenssment Questionnaire(12 months)
  • change of pulmonary arterial pressure(12 months)
  • reoccurrence of finger ulcers(12 months)
  • healing of finger ulcers(12 months)

研究者

发起方
GWT-TUD GmbH
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Immunoadsorption in Patients With Severe Systemic... | 临床试验